Stay updated on Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site footer’s revision identifier advances from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:27:55.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added, signaling a site-wide update. Several older documents and metadata items were removed, indicating a UI/structure refresh that streamlines the study record rather than altering core study data.
    Difference
    19%
    Check dated 2026-09-19T20:53:17.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, updating the site revision from v3.6.5 to v3.6.6. This denotes a minor system update that does not alter study details or displayed information.
    Difference
    0.1%
    Check dated 2026-08-29T22:05:13.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page’s revision label was updated to v3.6.5, indicating a minor internal update to the page. There are no evident changes to study details, eligibility criteria, or other user-facing content in the provided data.
    Difference
    0.1%
    Check dated 2026-08-08T19:28:49.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.4, replacing the previous v3.6.3. This appears to be a backend/template update rather than a content change to the study details.
    Difference
    0.1%
    Check dated 2026-07-25T11:49:41.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Revision v3.6.3 has been added and v3.6.2 removed, indicating a minor update to the page version of the study record rather than changes to study content.
    Difference
    0.1%
    Check dated 2026-07-03T23:53:21.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page.